Purchase Order N3239824P0310
Award Date 12/28/23
Potential Completion Date 1/12/25
Potential Value $136K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order was awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of biotechnology and genomic analysis products, for the delivery of one NovaSeq 6000 sequencing system. The $945,107.50 contract will support COVID-19 research at the Naval Medical Research Center in Fort Detrick, Maryland. The contract includes installation and training services. This requirement was a brand name-only solicitation with...
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA), a Defense agency, to Illumina, Inc. The contract has a ceiling value of $69,157.00 and a completion date of August 26, 2021. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing goods and services to support NAVSEA's nucleic acid sequencing needs, including reagents and controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used at...
- This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
- This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
- This is a firm fixed-price purchase order awarded by the Uniformed Services University of the Health Sciences, a Defense agency, to Illumina, Inc. for the provision of a NovaSeq X Plus Sequencing System. The $1,083,750.00 contract does not have a set-aside designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of providing sequencing systems, reagents, and related services to support research and...
- This is a firm fixed price purchase order contract awarded by the U.S. Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing equipment and reagents. The $102,361.40 contract is for the provision of NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract is not set aside for any...
- This is a $125,814.00 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc. The contract is for NovaSeq Silver Support services, which includes the provision of sequencing systems, reagents, and maintenance services to support genomic sequencing and analysis. Illumina is the sole manufacturer of the NovaSeq and related instruments used under this order. The contract has no set-aside designation and is not associated with a larger...
- This is a $752,450 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract...
- This is a $249,998.65 firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis instruments and reagents. The order is for NovaSeq X Series sequencing reagent kits and freight, with a period of performance through September 2025. This order is part of a broader indefinite delivery contract Illumina holds with the Department of the...
- This is a $86,760.00 firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The contract provides a NovaSeq 6000 sequencing service agreement with an estimated completion date of June 28, 2025. There is no set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the NIH, CDC, USDA, and VA...